Queensland-based private biopharma company, Xenome, has raised $10 million in funds in the form of convertible notes to fuel continued development of its flagship pain drug, Xen2174. [ + ]

Researchers have discovered 2,363 new DNA sequences corresponding to 730 regions on the human genome that were not charted in the reference map produced to date. [ + ]

The biotechnology sector has seen another quarter of strong growth, with the majors - CSL, ResMed and Cochlear - putting in healthy performances, according to PricewaterhouseCoopers' latest BioForum report. [ + ]

Over half the Australian population is either overweight or obese, with many experiencing corresponding health effects, such as cardiovascular disease and Type 2 diabetes. [ + ]

The Australian biotechnology industry is warming up for BIO 2010, to be held in Chicago from May 3-6, and Queensland is planning on being well represented at the world's largest biotech convention. [ + ]

LBT Innovations received two bits of good news today. First is that €2 million came through as a scheduled milestone payment from bioMérieux for LBT's MicroStreak technology. [ + ]

It would have been an inconceivable venture only a decade ago, before even the first full human genome had been published. But now a family of four has paid close to $US200,000 to sequencing company, Illumina, have their full genomes sequenced. [ + ]

In a paper published in the April 16 issue of the journal Cell, a team of researchers, led by scientists at the California Institute of Technology (Caltech), have taken steps toward a fuller understanding of this process by revealing just what happens to the organelle, its DNA (mtDNA), and its energy-producing ability when mitochondrial fusion fails. [ + ]

Fuelling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the US House of Representatives by Republican Mike Doyle (D-PA) and a bi-partisan host of co-sponsors. [ + ]

The All Ordinaries dipped back towards the 5,000 mark after seeing well over a month of consistent gains, including pipping 5,000 for the first time since the onset of the global financial crisis. [ + ]

Australian researchers release initial pancreatic cancer genomes as part of the International Cancer Genome Consortium. [ + ]

A gene associated with eye colour and skin pigmentation has been linked to survival rates in breast cancer patients. [ + ]

QRxPharma is another step closer to bringing its immediate release dual-opioid pain therapy, MoxDuoIR, to the market with the completion of one of two pivotal Phase III clinical trials held in the United States. [ + ]

Soybean is a remarkable plant, not only a protein rich food crop, but also usable in manifold industrial applications, such as the production of biofuel, emulsifiers, paints and even lipstick. [ + ]

ChemGenex working with FDA on validating a diagnostic that will allow anti-leukaemia drug, Omapro, to be approved. [ + ]